Related Articles
Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases
Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer
Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non‑squamous non‑small cell lung cancer
Pemetrexed versus vinorelbine treatment of advanced non‑squamous non-small cell lung cancer in elderly patients
Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer